IMRX
Immuneering Corp is a biopharmaceutical company focused on developing innovative therapies for oncology and neuroscience. Leveraging computational biology and translational medicine, the firm aims to create treatments that target disease mechanisms more precisely. Its pipeline includes novel drug candidates designed to improve patient outcomes by addressing unmet medical needs in cancer and neurological disorders. The company combines deep biological insights with advanced data science to accelerate drug discovery and development, striving to bring transformative therapies to market.
| Name | CIK | Position |
|---|---|---|
| loading... | ||